ID   AEBP1_RAT               Reviewed;        1128 AA.
AC   A2RUV9;
DT   20-MAY-2008, integrated into UniProtKB/Swiss-Prot.
DT   06-MAR-2007, sequence version 1.
DT   24-JUL-2024, entry version 115.
DE   RecName: Full=Adipocyte enhancer-binding protein 1;
DE            Short=AE-binding protein 1;
DE   AltName: Full=Aortic carboxypeptidase-like protein;
DE   Flags: Precursor;
GN   Name=Aebp1; Synonyms=Aclp;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=9624159; DOI=10.1074/jbc.273.25.15654;
RA   Layne M.D., Endege W.O., Jain M.K., Yet S.-F., Hsieh C.-M., Chin M.T.,
RA   Perrella M.A., Blanar M.A., Haber E., Lee M.-E.;
RT   "Aortic carboxypeptidase-like protein, a novel protein with discoidin and
RT   carboxypeptidase-like domains, is up-regulated during vascular smooth
RT   muscle cell differentiation.";
RL   J. Biol. Chem. 273:15654-15660(1998).
RN   [3]
RP   TISSUE SPECIFICITY.
RX   PubMed=11738825; DOI=10.1016/s0378-1119(01)00771-5;
RA   Ro H.-S., Kim S.-W., Wu D., Webber C., Nicholson T.E.;
RT   "Gene structure and expression of the mouse adipocyte enhancer-binding
RT   protein.";
RL   Gene 280:123-133(2001).
CC   -!- FUNCTION: As a positive regulator of collagen fibrillogenesis, it is
CC       probably involved in the organization and remodeling of the
CC       extracellular matrix (By similarity). May positively regulate MAP-
CC       kinase activity in adipocytes, leading to enhanced adipocyte
CC       proliferation and reduced adipocyte differentiation. May also
CC       positively regulate NF-kappa-B activity in macrophages by promoting the
CC       phosphorylation and subsequent degradation of I-kappa-B-alpha (NFKBIA),
CC       leading to enhanced macrophage inflammatory responsiveness. Can act as
CC       a transcriptional repressor. {ECO:0000250|UniProtKB:Q640N1,
CC       ECO:0000250|UniProtKB:Q8IUX7}.
CC   -!- SUBUNIT: Interacts with different types of collagen, including
CC       collagens I, III, and V (By similarity). Interacts with GNG5, NFKBIA,
CC       MAPK1, MAPK3 and PTEN. May interact with calmodulin. Interaction with
CC       MAPK1 may stimulate DNA-binding. Binds to DNA in vitro.
CC       {ECO:0000250|UniProtKB:Q640N1, ECO:0000250|UniProtKB:Q8IUX7}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:Q640N1}.
CC   -!- TISSUE SPECIFICITY: Expressed in aorta. {ECO:0000269|PubMed:11738825,
CC       ECO:0000269|PubMed:9624159}.
CC   -!- DEVELOPMENTAL STAGE: Highly expressed in quiescent cells.
CC       {ECO:0000269|PubMed:9624159}.
CC   -!- DOMAIN: The F5/8 type C domain binds to different types of collagen,
CC       including collagens I, III, and V. {ECO:0000250|UniProtKB:Q8IUX7}.
CC   -!- PTM: Phosphorylated by MAPK1 in vitro. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the peptidase M14 family. {ECO:0000305}.
CC   -!- CAUTION: Although related to peptidase M14 family, lacks the active
CC       site residues and zinc-binding sites, suggesting that it has no
CC       carboxypeptidase activity. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC133065; AAI33066.1; -; mRNA.
DR   RefSeq; NP_001094440.1; NM_001100970.1.
DR   AlphaFoldDB; A2RUV9; -.
DR   SMR; A2RUV9; -.
DR   STRING; 10116.ENSRNOP00000018846; -.
DR   MEROPS; M14.951; -.
DR   GlyCosmos; A2RUV9; 1 site, No reported glycans.
DR   GlyGen; A2RUV9; 1 site.
DR   PhosphoSitePlus; A2RUV9; -.
DR   PaxDb; 10116-ENSRNOP00000018846; -.
DR   Ensembl; ENSRNOT00000018846.7; ENSRNOP00000018846.7; ENSRNOG00000013720.7.
DR   Ensembl; ENSRNOT00055051257; ENSRNOP00055042226; ENSRNOG00055029591.
DR   Ensembl; ENSRNOT00060055154; ENSRNOP00060045599; ENSRNOG00060031827.
DR   Ensembl; ENSRNOT00065034335; ENSRNOP00065027494; ENSRNOG00065020330.
DR   GeneID; 305494; -.
DR   KEGG; rno:305494; -.
DR   UCSC; RGD:1306922; rat.
DR   AGR; RGD:1306922; -.
DR   CTD; 165; -.
DR   RGD; 1306922; Aebp1.
DR   eggNOG; KOG2649; Eukaryota.
DR   GeneTree; ENSGT00940000158323; -.
DR   HOGENOM; CLU_006722_0_1_1; -.
DR   InParanoid; A2RUV9; -.
DR   OMA; YIRRQKR; -.
DR   OrthoDB; 5490979at2759; -.
DR   PhylomeDB; A2RUV9; -.
DR   TreeFam; TF315592; -.
DR   PRO; PR:A2RUV9; -.
DR   Proteomes; UP000002494; Chromosome 14.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0004180; F:carboxypeptidase activity; ISO:RGD.
DR   GO; GO:0005518; F:collagen binding; ISS:UniProtKB.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0004181; F:metallocarboxypeptidase activity; IBA:GO_Central.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0006518; P:peptide metabolic process; IBA:GO_Central.
DR   GO; GO:0016485; P:protein processing; IBA:GO_Central.
DR   GO; GO:1904026; P:regulation of collagen fibril organization; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   CDD; cd00057; FA58C; 1.
DR   CDD; cd11308; Peptidase_M14NE-CP-C_like; 1.
DR   Gene3D; 2.60.40.1120; Carboxypeptidase-like, regulatory domain; 1.
DR   Gene3D; 2.60.120.260; Galactose-binding domain-like; 1.
DR   Gene3D; 3.40.630.10; Zn peptidases; 1.
DR   InterPro; IPR008969; CarboxyPept-like_regulatory.
DR   InterPro; IPR000421; FA58C.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   InterPro; IPR000834; Peptidase_M14.
DR   InterPro; IPR050753; Peptidase_M14_domain.
DR   PANTHER; PTHR11532:SF48; ADIPOCYTE ENHANCER-BINDING PROTEIN 1; 1.
DR   PANTHER; PTHR11532; PROTEASE M14 CARBOXYPEPTIDASE; 1.
DR   Pfam; PF13620; CarboxypepD_reg; 1.
DR   Pfam; PF00754; F5_F8_type_C; 1.
DR   Pfam; PF00246; Peptidase_M14; 1.
DR   PRINTS; PR01217; PRICHEXTENSN.
DR   SMART; SM00231; FA58C; 1.
DR   SMART; SM00631; Zn_pept; 1.
DR   SUPFAM; SSF49464; Carboxypeptidase regulatory domain-like; 1.
DR   SUPFAM; SSF49785; Galactose-binding domain-like; 1.
DR   SUPFAM; SSF53187; Zn-dependent exopeptidases; 1.
DR   PROSITE; PS00132; CARBOXYPEPT_ZN_1; 1.
DR   PROSITE; PS01285; FA58C_1; 1.
DR   PROSITE; PS01286; FA58C_2; 1.
DR   PROSITE; PS50022; FA58C_3; 1.
DR   PROSITE; PS52035; PEPTIDASE_M14; 1.
PE   2: Evidence at transcript level;
KW   Calmodulin-binding; DNA-binding; Glycoprotein; Reference proteome;
KW   Repressor; Secreted; Signal; Transcription; Transcription regulation.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000255"
FT   CHAIN           26..1128
FT                   /note="Adipocyte enhancer-binding protein 1"
FT                   /id="PRO_0000333191"
FT   DOMAIN          375..532
FT                   /note="F5/8 type C"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00081"
FT   DOMAIN          555..896
FT                   /note="Peptidase M14"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01379"
FT   REGION          40..368
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          382..547
FT                   /note="Required for DNA-binding and interaction with
FT                   NFKBIA"
FT                   /evidence="ECO:0000250"
FT   REGION          413..616
FT                   /note="Interaction with MAPK1 and MAPK3"
FT                   /evidence="ECO:0000250"
FT   REGION          547..977
FT                   /note="Interaction with PTEN"
FT                   /evidence="ECO:0000250"
FT   REGION          933..1128
FT                   /note="Required for transcriptional repression"
FT                   /evidence="ECO:0000250"
FT   REGION          998..1128
FT                   /note="Interaction with MAPK1 and MAPK3"
FT                   /evidence="ECO:0000250"
FT   REGION          1027..1056
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        69..159
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        174..188
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        211..252
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        261..284
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        317..368
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        520
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   1128 AA;  128061 MW;  EC2A4DDC46240A4F CRC64;
     MAAVRTASLL CGLLALLALC PEGSPQTVLT DDEIQEFLEG FLSEFETQSP PREDDVEAQP
     LPEPTQRARK SKAGGKPRAD AEAPPEKNKD KEKKGKKDKG PKAAKHLEGS TRPTKKPKEK
     PPKATKKPKE KPPKATKKPK EKPPKATKKP KEKPPKATKR PSAGKRFSTV APLETPERSL
     TSPSNPGTRE LPEERGRTSL NTWQGQGEET QVEARQHRPE PEEETEMPTL DYNDQIERED
     YEDFEYIRRQ KQPRPTPSRK RIWPEPPEEK TQEPEERKEV DPPLKPLLPP DYGDGYLIPN
     YDDLDYYFPH PPPQKPDVGQ EVDEEKEELK KPKKEGSSPK EDTEDKWAAE KNKDHKAGPR
     KGEELEEEWG PVEKIKCPPI GMESHRIEDN QIRASSMLRH GLGAQRGRLN MQAGANEDDY
     YDGAWCAEDE SQTQWIEVDT RRTTRFTGVI TQGRDSSIHD DFVTTFFVGF SNDSQTWVMY
     TNGYEEMTFH GNVDKDTPVL SELPEPVVAR FIRIYPLTWN GSLCMRLEVL GCPVTPVYSY
     YAQNEVVTTD SLDFRHHSYK DMRQLMKVVN EECPTITRTY SLGKSSRGLK IYAMEISDNP
     GEHELGEPEF RYTAGMHGNE VLGRELLLLL MQYLCHEYRD GNPRVRNLVQ DTRIHLVPSL
     NPDGYEVAAQ MGSEFGNWAL GLWTEEGFDI FEDFPDLNSV LWAAEEKKWV PYRVPNNNLP
     IPERYLSPDA TVSTEVRAII SWMEKNPFVL GANLNGGERL VSYPYDMART PSQEQLLAAA
     LAAARGEDED EVSEAQETPD HAIFRWLAIS FASAHLTMTE PYRGGCQAQD YTSGMGIVNG
     AKWNPRSGTF NDFSYLHTNC LELSIYLGCD KFPHESELPR EWENNKEALL TFMEQVHRGI
     KGVVTDEQGI PIANATISVS GINHGVKTAS GGDYWRILNP GEYRVTAHAE GYTSSAKICN
     VDYDIGATQC NFILARSNWK RIREILAMNG NRPILRVDPS RPMTPQQRRL QQRRLRYRLR
     MREQMRLRRL NSTTGPATSP TPALTLPPSP TPGSTSRLWE ILPTTAAGWE ESETETYTEV
     VTEFETEYGP DLEVEELEEE EEEEEEMDTG LTFPVTTVET YTVNFGDF
//
